Ireland
--:--IST
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Migraine
Clinical trial register · Canada

Migraine Trials in Canada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6518 matching records held by the registry are in this view. Synced 05 Oct 2026, 03:18 UTC
6518
Studies in scope
all four open statuses
3499
Recruiting now
open to new participants
885
Lead sponsors
across recruiting studies
Top sites
London 4 Ottawa 3 Edmonton 2 Toronto 2 Calgary 2
Narrow the registerReset
Recruitment status
Phase
Site location
London4 Ottawa3 Edmonton2 Toronto2 Calgary2
All 16 locations
Target enrolment
to

Migraine trials in Canada

10 of 6518 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in Youth
NCT07772427Migraine, Migraine Headache
University of Calgary
Not applicable
30
Calgary
2026-10
Recruiting
Study of EVO756 in Adults With Migraine
NCT07616128Migraine
Evommune, Inc.
Phase 2
330
Québec
2026-07-29
Not yet open
Evaluation of a Mind-Body Based Approach for Chronic Pain Treatment
NCT07143396Chronic Pain, Migraine, Chronic Pain Syndrome
University of the Fraser Valley
Not applicable
100
Chilliwack
2025-10
By invitation
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
NCT06428838Migraine, Chronic Migraine
Dr George Medvedev
Phase 3
102
New Westminster, Surrey
2025-05-05
Active, closed
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
NCT06543914Migraine
AbbVie
Observational
1,314
Calgary, Vancouver, Saint John, Halifax, London, Ottawa, Toronto, Lévis
2024-11-26
Active, closed
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
NCT06616194Migraine
Pfizer
Phase 3
200
Edmonton, Red Deer, London
2024-11-15
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
NCT05156398Migraine
Pfizer
Phase 3
640
Vancouver
2022-02-28
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
NCT05164172Migraine
H. Lundbeck A/S
Phase 3
600
Victoria, Ajax, London
2021-12-01
Active, closed
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
NCT03836040Migraine
Amgen
Phase 3
457
Edmonton, London, Ottawa, Toronto
2019-07-19
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 5 October 2026. https://priyalifescience.com/clinical-trials-canada/condition/migraine

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,518 studies in total at the last sync on 05 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Migraine.

How many Migraine trials are recruiting in Canada?

4 of the 10 studies on this page are recruiting new participants as of the 05 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Migraine), 10 studies
PhaseStudiesRecruitingShare
Phase 35250%
Not applicable2020%
Observational2120%
Phase 21110%

Most active sponsors

Lead sponsors with the most studies (Migraine)
Lead sponsorStudiesRecruiting
AbbVie21
Pfizer21
Amgen10
Dr George Medvedev10
Evommune, Inc.11
H. Lundbeck A/S11
University of Calgary10
University of the Fraser Valley10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.